Sai Life Sciences inks strategic agreement to set up Schrödinger’s first dedicated offshore Research Laboratories in India
10 January 2023
Download
SWIXX and Kyowa Kirin expand Partnership for Rare Disease Portfolio to 13 Countries in Europe
19 December 2022
Download
Innovationen in der Biotechnologie #6: M&A Aktivitäten gewinnen an Dynamik
10 December 2022
Download
Innovationen in der Biotechnologie #5: Auf der Suche nach den versteckten Perlen
22 November 2022
Download
Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension
16 November 2022
Download
Boditech Med and SphingoTec close global licensing agreement for kidney function biomarker Proenkephalin A 119-159 (penKid)
15 November 2022
Download
Findet Biotech den Weg aus der Versenkung?
19 October 2022
Download
Swixx and Kyowa Kirin enter into Partnership for Rare Disease Medicines Portfolio in Poland
10 October 2022
Download
Shape Memory Medical Completes Enrollment in the AAA-SHAPE Early Feasibility Study
29 August 2022
Download
Innovationen in der Biotechnologie #3: Junge Firmen im Visier der Pharmakonzerne
24 August 2022
Download
Upstream Bio Announces Dosing of First Patient in a Phase 1b Clinical Trial of UPB-101 in Asthma
9 August 2022
Download
Zuger Firma finanziert die Medikamente der Zukunft - Interview with Dr Andreas Wicki
23 July 2022
Download
Vascular Dynamics Completes $20 Million Equity Financing to Support Further Clinical Evaluations of MobiusHD Device
12 July 2022
Download
Innovationen in der Biotechnologie #2: Von schmerzlindernd bis lebensnotwendig
6 July 2022
Download
Biotechs gehen in den Turbulenzen unter
2 July 2022
Download
Galera Announces Results from Phase 1 Stage of GRECO-1 Trial of Rucosopasem with SBRT for NSCLC
29 June 2022
Download
Aculys Pharma initiates collaboration with Ubie with the aim of building a “sleep ecosystem”
29 June 2022
Download
Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic
28 June 2022
Download
Acrivon Therapeutics Receives FDA Clearance for Innovative Phase 2 Trial to Treat Ovarian, Endometrial and Urothelial Cancer Patients Based on Predicted Sensitivity to ACR-368
22 June 2022
Download
Galecto Announces First Patient Enrolled in Phase 2 Trial of GB1211 in Combination with Atezolizumab for First-Line Treatment of NSCLC
16 June 2022
Download
Dren Bio Announces $65 Million Series B Financing to Advance its Lead Asset into the Clinic
14 June 2022
Download
Innovationen in der Biotechnologie #1: Viel mehr als nur Impfstoffe
13 June 2022
Download
Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension
8 June 2022
Download
Bristol Myers Squibb to Acquire HBM Portfolio Company Turning Point Therapeutics for USD 4.1 billion in cash
3 June 2022
Download
Upstream Bio Launches with $200M Series A Financing to Advance Novel Therapeutics for Allergic and Inflammatory Diseases
2 June 2022
Download